Latest Dabigatran Stories
LOS ANGELES, May 18, 2015 /PRNewswire-USNewswire/ -- Good Samaritan Hospital is one of the first hospitals in California to offer patients with non-valvular atrial fibrillation (a-fib) an alternative
WATCHMAN offers patients with atrial fibrillation alternative to warfarin therapy ANN ARBOR, Mich., May 15, 2015 /PRNewswire-USNewswire/ -- The University of Michigan Frankel Cardiovascular
Legal-Bay, Lawsuit Money Advance Firm, says Boehringer submitted a supplemental new drug application to the FDA for Pradaxa so it can be used to treat the prophylaxis of deep venous thrombosis (DVT)
RIDGEFIELD, Conn., April 6, 2015 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S.
-- Data show initial therapy in newly diagnosed NVAF patients diverged from guideline recommendations RIDGEFIELD, Conn., March 16, 2015 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals,
BOCA RATON, Fla., March 12, 2015 /PRNewswire/ -- Breckenridge Pharmaceutical, Inc. announced today that it has filed an ANDA with a Paragraph IV certification for dabigatran etexilate
-- First BLA submission for an investigational reversal agent for a novel oral anticoagulant RIDGEFIELD, Conn., March 2, 2015 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc.
The report’s publication comes as dozens of people pursue Xarelto lawsuits for internal bleeding and other serious complications allegedly related to its use. New
Xarelto Bleeding Lawsuits Filed In Federal And State Courts Allege The Prescription Blood Thinner Causes Uncontrollable Or Fatal Bleeding Due To The Lack Of An Antidote Columbus,
Xarelto Drug Safety Label Warns Bleeding Is A Common Adverse Reaction Of The Blood Thinner And Xarelto Bleeding Side-Effects Lawsuits Claim The Anticoagulant Does Not Have An Antidote Should Severe
- To say in too many words; to express verbosely.
- To express in too many words: sometimes used reflexively.
- The leading idea or a repeated phrase, as of a song or ballad; the refrain; burden.